Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Dr. Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Dr. Inge von Alvensleben , Medicine and Dentistry at  Kardiozentrum , Bolivia

Inge Barbara von Alvensleben is a pediatric cardiologist based in La Paz, Bolivia. Born in Freiburg, Germany, on May 8, 1972, she completed her medical studies at Charité – Humboldt-Universität Berlin. She has dedicated much of her career to improving child healthcare, especially in underserved regions. With a background in pediatrics and pediatric cardiology, she has worked in diverse environments, including refugee camps in Iraq and prisons in Bolivia. Since 2018, she has been a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz. Dr. von Alvensleben is passionate about advancing pediatric healthcare through research and clinical practice, focusing on congenital heart diseases and high-altitude health challenges. Her work is internationally recognized, with numerous publications in leading medical journals.

Publication Profile

Scopus

Academic Background🎓

Inge Barbara von Alvensleben completed her medical studies at Charité – Humboldt-Universität Berlin, Germany, from 1993 to 2000. She then pursued a residency in pediatrics at Neubrandenburg Hospital, Germany, from 2000 to 2003. In 2008, she earned a diploma in “Adolescence – Integral Health Approach” from Universidad Nacional del Comahue, Argentina. She further enhanced her expertise by completing courses in Basic Life Support (2011) and Pediatric Advanced Life Support (2011) from the American Heart Association. In 2013, she completed her thesis on the percutaneous closure of atrial septal defects at Munich, Germany. Her graduation in pediatric cardiology took place in 2018, in Frankfurt, Germany. These academic milestones have shaped her comprehensive expertise in both pediatric healthcare and cardiology, with a particular focus on high-altitude medicine and congenital heart disease.

Professional Background🏅

Dr. Inge Barbara von Alvensleben’s professional experience spans several countries and diverse clinical settings. After completing her pediatric fellowship at Bonhoeffer-Klinik Neubrandenburg (2000-2003), she volunteered as a pediatrician in a Kurdish refugee camp in Iraq (2004), providing care to displaced populations. In Bolivia, she worked at Hospital La Paz as an intern (2005-2006) before engaging in various volunteer projects, including serving as a pediatrician in La Paz prisons and working with street children (2006-2009). From 2009 to 2013, she worked as a pediatrician at Kardiozentrum and Fundación Cardioinfantil La Paz. She completed her pediatric cardiology residency at Kinderherzzentrum Giessen, Germany, from 2014 to 2018. Since November 2018, she has been practicing as a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz, where she continues to care for children with congenital heart diseases and contribute to research in pediatric cardiology and high-altitude health.

Awards and Honors🏆

Throughout her career, Dr. Inge Barbara von Alvensleben has been recognized for her contributions to pediatric cardiology and healthcare. While specific awards are not listed, her work in pediatric cardiology, particularly in resource-limited settings, has earned her considerable recognition within international medical communities. She is highly respected for her research into the effects of high-altitude environments on pediatric health, especially regarding congenital heart disease. Her publications in esteemed journals, such as Hypertension and Cardiology in the Young, showcase the impact of her work in understanding and treating conditions in challenging environments. Her dedication to improving the health of children worldwide, especially in Bolivia, has brought her ongoing professional recognition. As a faculty member at medical conferences and contributor to international research projects, Dr. von Alvensleben continues to influence pediatric cardiology both in clinical practice and academic settings.

Research Focus🔬

Dr. Inge Barbara von Alvensleben’s research focuses on pediatric cardiology, with a particular interest in congenital heart diseases and the effects of high-altitude living on cardiovascular health. She has contributed to groundbreaking studies on the adaptation of children with congenital heart conditions living at high altitudes, such as those in Bolivia. Her work investigates the physiological challenges faced by newborns in high-altitude environments and how these conditions may affect the development of pulmonary hypertension and other cardiovascular issues. Dr. von Alvensleben has also researched the use of innovative interventional techniques, such as the percutaneous closure of atrial septal defects, and their impact on patient outcomes. Her work aims to improve the management and treatment of pediatric heart conditions, especially in low-resource settings. Through her research, she seeks to bridge the gap in pediatric healthcare between developed and developing nations, particularly in high-altitude regions.

Publication Top Notes

 Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia. Experimental Physiology.

Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia

Conclusion

Dr. Inge Barbara von Alvensleben is highly deserving of the “Best Researcher Award.” Her dedication to improving pediatric healthcare, particularly in challenging environments like Bolivia, demonstrates her unwavering commitment to advancing medical knowledge and patient care. She has proven her expertise through a series of influential studies, making her a trailblazer in pediatric cardiology. Her work continues to inspire both researchers and healthcare professionals globally, and she has significantly contributed to understanding the complexities of congenital heart diseases and their management in resource-limited regions. Her innovative approach, depth of knowledge, and passion for improving child health are qualities that make her a top candidate for this prestigious award.

 

 

Dan Yan | Medicine and Dentistry | Best Researcher Award

Dan Yan | Medicine and Dentistry | Best Researcher Award 

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. 📚✨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.

 

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: Whether a specific approach is justified to tackle the challenges?

Antibiotic combinations prediction based on machine learning to multicentre clinical data and drug interaction correlation

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment

β-Elemene in zedoary turmeric oil injection induces dyspnea by binding to hemoglobin and upregulating HIF-1α

Predicting coronary heart disease in Chinese diabetics using machine learning

Editorial: Benefits and risks of drug combination therapy for chronic metabolic diseases

Quality assessment and control of Shuanghuanglian Lyophilized Injection based on cell response spectrum